Pagina inicial
Continue Watching
Últimos vídeos
Últimos vídeos
Brightcove Home Latest Listing
Oncology
Oncology
Brightcove Cards Listing
Hematology
Hematology
Brightcove Cards Listing
Popular em MedEnrich
Popular em MedEnrich
Popular in Sem nome
Mieloma múltiplo11m 40s
How I Treat Relapsed Refractory Multiple Myeloma
Treating relapsed or refractory multiple myeloma (RRMM) can be complex and typically involves a combination of therapies based on the patient's previous treatments, overall health, and specific disease characteristics.
relapsed refractory multiple myeloma
treatment
combination treatment
1

How I Treat Relapsed Refractory Multiple Myeloma
Myelodysplastic Syndromes17m 28s
A evolução do hipometilantes de DNA ao longo do tempo no tratamento da SMD/LMA e o papel da mutação TP53
Assista a uma vídeo aula que aborda a evolução dos hipometilantes de DNA ao longo do tempo no tratamento da SMD/LMA e o papel da mutação TP53
sdm
lma
hipometilantes
dna
tp53
ronald
ronald feitosa
ronald feitosa pinheiro
1

A evolução do hipometilantes de DNA ao longo do...
Oncology21m 26s
Perspectivas do uso da carmustina nos gliomas
Vídeo gravado durante evento de lançamento da Carmustina pela Dr. Reddy's, realizado na cidade de São Paulo, para uma audiência de oncologistas.
tumores cerebrais
glioblastoma
1

Perspectivas do uso da carmustina nos gliomas
Myelodysplastic Syndromes8m 45s
Current Challenges in MDS Diagnosis and Consequences
Bone marrow examination-based diagnosis of MDS with either biopsy or aspirate remains standard of care but is associated with pain, bleeding, difficulty to use the same in elderly patients and hIgh interobserver variability.
non invasive mds diagnosis
web based mds diagnosis tools
1

Current Challenges in MDS Diagnosis and Consequences
14m 46s
ESMO 2022 Breast Cancer Comprehensive Coverage
View comprehensive coverage of Breast Cancer from ESMO 2022
dose dense adjuvant chemotherapy
esmo
keynote -522
monarch -3 study
1

ESMO 2022 Breast Cancer Comprehensive Coverage
15m 43s
Treatment sequencing - integrating CDK4-6 inhibitors with hormonal therapy in HR+ve ,Her2 Negative Metastatic Breast Cancer
CDK4/6 inhibitors, combined with hormonal therapy, are key in treating HR+/HER2- metastatic breast cancer. Treatment sequencing after progression focuses on personalized strategies, including SERDs, PI3K/mTOR inhibitors, and chemotherapy.
cdk4/6 inhibitors
hormonal therapy
personalized treatment strategies
treatment sequencing
1

Treatment sequencing - integrating CDK4-6...
14m 46s
ESMO 2022 Breast Cancer Comprehensive Coverage
View comprehensive coverage of Breast Cancer from ESMO 2022
dose dense adjuvant chemotherapy
esmo
keynote -522
monarch -3 study
1

ESMO 2022 Breast Cancer Comprehensive Coverage
Myelodysplastic Syndromes3m 18s
Anemia of MDS
Anemia is common feature of MDS with 90% patients having anemia at diagnosis or initial presentation. Anemia not only impacts quality of life but is also prognostic in nature.
anemia
mds
transfusion dependence
1

Anemia of MDS
15m 43s
Treatment sequencing - integrating CDK4-6 inhibitors with hormonal therapy in HR+ve ,Her2 Negative Metastatic Breast Cancer
CDK4/6 inhibitors, combined with hormonal therapy, are key in treating HR+/HER2- metastatic breast cancer. Treatment sequencing after progression focuses on personalized strategies, including SERDs, PI3K/mTOR inhibitors, and chemotherapy.
cdk4/6 inhibitors
hormonal therapy
personalized treatment strategies
treatment sequencing
1

Treatment sequencing - integrating CDK4-6...
Farmacia23m 30s
Avaliação de novas terapias e seu impacto da teoria à prática
Avaliação de novas terapias é um processo complexo que necessita de atuação interdisciplinar para sua execução.
farmacêutico
oncologia
teoria
prática
1
